US FOOD AND DRUG ADMINISTRATION
Sonam Wangchuk seeks President Droupadi Murmu's intervention in Ladakh, accuses LG V K Saxena of smear campaign
Sonam Wangchuk called for presidential intervention regarding the situation in Ladakh and Arunachal Pradesh. He claimed that Ladakh has experienced significant repression since it became a Union Territory. Wangchuk accused the Lieutenant Governor of engaging in a smear campaign against him and other local leaders. He expressed concerns over various policies that favor corporatization and harm local communities.
FDA suspends 43 food business licences across Maharashtra during Diwali inspections
Maharashtra FDA took action during a special Diwali enforcement drive by suspending 43 food business licenses. Inspections were conducted across seven divisions in the state, which included major cities like Mumbai and Nashik. Violations of food safety requirements led to the suspensions and the seizure of food articles worth Rs 63.09 lakh.
Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experiment
Researchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study indicates that Zileuton could block the inflammation that leads to anaphylaxis. While it works in mice, clinical trials in humans are just beginning. This research highlights a new biological pathway related to food allergies and the immune response.
Rubio to visit France on first post-midterm foreign trip to face questions on Trump policies
US Secretary of State Marco Rubio will attend the G7 foreign ministers meeting in France this weekend. This trip follows significant Republican losses in the midterm elections, raising questions about Trump's international policies. Rubio is expected to address various global issues, including the Iran and Russia-Ukraine conflicts. The meeting aims to cover topics like energy security and support for Ukraine amidst ongoing challenges.
Food Noise: Why do you keep asking for a snack even after you’re full? Here's why your brain keeps revolving around food
Dinner is over, but your mind keeps drifting back to what’s in the kitchen. A Penn State survey found that 18% of U.S. adults reported frequent or constant food noise. The findings show who reported it more often, while leaving open the question of what makes those thoughts stick.
- Go To Page 1
FDA suspends 105 food business licences, Blinkit, Zepto among them; orders closure of 7 outlets
Maharashtra FDA has suspended the licences of 105 food outlets, including those linked to Blinkit and Zepto, and ordered seven establishments to shut following inspections ahead of Diwali. The two-day drive uncovered hygiene and food safety violations, leading to the seizure of 39,485 kg of food articles worth Rs 1.35 crore.
FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilities
The US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspectors found discarded documents related to key manufacturing processes, highlighting compliance concerns. To ensure safe medicines, drugmakers are urged to scrutinize their supply chains and monitor suppliers effectively. Additionally, human errors contributed significantly to production incidents, affecting operations and batch release timelines.
Fake US officials, forged court orders and gold pick-ups: How a Hyderabad call centre targeted nearly 2 million citizens and stole Rs 261 crore
The Enforcement Directorate has uncovered a fake call centre syndicate that allegedly defrauded US citizens of millions. Investigators arrested seven individuals involved in this international money laundering operation. The syndicate impersonated US federal officials and pressured victims to pay money through various channels. Seized evidence includes forged documents and the personal information of numerous US nationals. The investigation continues to identify additional participants and trace the flow of illegal funds.
Why anti-Trump Republican Thomas Massie wants Pete Hegseth impeached; what the defense secretary can do to avoid the situation
Rep. Thomas Massie plans to push for the impeachment of Defense Secretary Pete Hegseth when Congress reconvenes. Massie outlined allegations against Hegseth, including abuse of power and unauthorized military actions. He suggests that Hegseth's resignation would halt the impeachment process entirely. The Pentagon has expressed support for Hegseth, affirming his leadership and commitment. A House vote would occur if Massie proceeds with the impeachment articles.
Congressman Subramanyam vows to end 'forever wars', fight tariffs, hold Trump admin accountable
Indian-American Congressman Suhas Subramanyam recently won re-election in Virginia's 10th Congressional District. He pledged to address concerns about rising costs, healthcare cuts, and federal workforce reductions. Subramanyam committed to ending "forever wars" and fighting unnecessary tariffs to lower costs. His victory reflects significant gains by Democrats in the recent midterm elections. Subramanyam aims to collaborate with the community to drive changes in Washington.
Zydus Q2 profit falls 27% despite 29% revenue growth; consumer wellness sales surge 76%
Zydus Lifesciences reported a 29% year-on-year rise in Q2FY27 revenue to Rs 7,909 crore, driven by growth across key markets and a 76% surge in consumer wellness. However, net profit fell 27% to Rs 925 crore, while EBITDA declined 6%. The company continues to advance its specialty drug pipeline.
Democrats took Capitol Hill. Trump still has a Veto. What happens next and who can make their case for 2028?
Democrats are set to take control of the House and Senate after the 2026 midterm elections. President Donald Trump still has the power to veto their bills. This could be a test for Democats on how they handle that power and bring policies which could shape their pitch to voters in 2028.
Wockhardt seeks 14-year data shield for India-made drugs
Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime + zidebactam), to treat complicated urinary tract infection, including acute pyelonephritis or severe kidney infections. Wockhardt has showcased six drugs to treat antimicrobial resistance (AMR).
Blood pressure drug recall: FDA flags thousands of bottles after pills fail quality tests; here's what to check
A major recall has been initiated for certain blood pressure medications produced by Macleods Pharma USA. Patients are urged to verify their medications against specific lot numbers and reach out to their pharmacists. The FDA indicates that this recall stems from issues with dissolution specifications. Failure to comply with proper guidelines could pose serious health risks from unmanaged hypertension.
Maharashtra FDA suspends 19 food licences; acts against Patanjali distributor over 'adulteration'
In a recent operation, the Maharashtra FDA suspended licenses of 19 food business operators for violations. They seized food articles worth over Rs 9 crore across multiple divisions in the state. This included significant amounts of Patanjali cow ghee found to be misbranded and adulterated. Further, the FDA registered FIRs, arrested several individuals, and sealed multiple establishments for serious hygiene issues.
Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%
Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology sector recorded significant revenue growth, indicating strong demand for its products. Zaynich received US FDA approval for complicated urinary tract infections, serving as a milestone for Indian pharmaceuticals.
Ajay Devgn's Vimal Elaichi ad controversy: FDA chief Tukaram Munde says proceedings will continue despite Drishyam 3 actor's High Court plea
Ajay Devgn has filed a petition with the Bombay High Court in response to a notice from the Maharashtra FDA regarding his appearance in Vimal Elaichi ads. The FDA contends that these ads promote a banned product. Commissioner Tukaram Munde affirmed that legal procedures will be followed. Read on!
UC innovations make TIME’s Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?
From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyond laboratories. Daraxonrasib, developed from discoveries at UCSF, received FDA approval in August. Meanwhile, UC Berkeley alumnus Tony Hong’s Strutt ev¹ uses sensors and voice controls to make everyday mobility easier.
4 FDA officials suspended over alleged unauthorised raids in Pune, 21 others to face inquiry
Four officials from the Maharashtra Food and Drug Administration have been suspended for conducting unauthorized raids. The Chief Minister approved this action following allegations regarding the officials' misconduct. A departmental inquiry is also being initiated against 21 other officials involved in the matter. This inquiry will investigate the actions of officials from the Thane and Pune divisions. Further action will be determined based on the findings of this investigation.
Actor Ajay Devgn moves Bombay High Court against FDA notice over Vimal Elaichi ads
Ajay Devgn has filed a petition in the Bombay High Court against the FDA's show-cause notice. The notice involves his advertisements for 'Vimal Elaichi', linked to banned products in Maharashtra. FDA Commissioner Tukaram Mundhe confirmed completed investigations regarding violations by several actors. Similar notices were issued to Shah Rukh Khan and Tiger Shroff for the same reason. The court is scheduled to hear the matter on November 4.
Pan masala ad proceedings against 3 actors complete, matter up for adjudication next: FDA chief
Maharashtra FDA has completed its investigation into actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged violations of state rules through Vimal Pan Masala advertisements. The matter will be referred for adjudication next week, with the regulator proceeding despite Devgn approaching the Bombay High Court.
Karnataka govt pauses circular on medicine price disclosure by hospitals
In a significant move, the Karnataka government declared it would not proceed with a disputed circular aimed at mandating hospitals to disclose medicine pricing information. This decision emerged during a High Court review related to the circular's compliance and repercussions. The proposal required hospitals to clearly present procurement costs, MRP, and patient billing in their invoices.
Butter Recall: Miyoko’s Creamery plant-based butter pulled from stores in 10 states over contamination concerns-here's how to identify the product being recalled
Miyoko’s Creamery European Style Salted Plant Milk Butter has been recalled in ten US states due to contamination concerns. The FDA reported possible yeast, mold, and E. coli in the affected product. Around 1,304 cases of the 8-ounce butter are involved, impacting several states including Florida and New Jersey. Consumers are advised to check packaging details to determine if they have the recalled butter.
Anthropic's Claude cut Enveda's drug records' review time by 89%
Colorado-based biotechnology company Enveda developed a CMC Document Processor to help reviewers identify errors, inconsistencies and potential quality issues across these records.
Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%
Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker North American sales. India revenue grew 12%, while US regulatory approval and a biosimilar partnership supported its product pipeline.
AI halves drug discovery times, but =trial bottleneck remains a costly reality
Novo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory automation and research.
Mark Cuban says AI hack agents are like cockroaches, but can be controlled
Cuban, famous for his role on business reality show "Shark Tank" and his involvement in the Dallas Mavericks NBA team, ventured into healthcare when he started the online pharmacy Cost Plus Drug Company in 2022 with a standard pricing scheme: the cost it pays for the drug, plus 15%.
Load More
